Article

Influence of Detrusor Overactivity on Storage Symptoms Following Potassium-titanyl-phosphate Photoselective Vaporization of the Prostate

Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
Urology (Impact Factor: 2.13). 12/2009; 75(6):1460-6. DOI: 10.1016/j.urology.2009.09.065
Source: PubMed

ABSTRACT To investigate whether the presence of detrusor overactivity (DO) influences storage symptoms after photoselective laser vaporization of the prostate (PVP) for benign prostatic hyperplasia (BPH).
A total of 149 patients who underwent PVP were included in this retrospective study. All patients underwent a preoperative evaluation including multichannel video urodynamics. The efficacy of the PVP was assessed at 1, 3, 6, and 12 months postoperatively using the International Prostate Symptom Score (IPSS), uroflowmetry, postvoid residual urine volume, and 3-day frequency-volume charts (FVC). The patients were stratified into 2 groups (DO group vs non-DO group).
The IPSS and FVC showed that the storage symptoms were reduced significantly after the PVP in both groups (P<.05). Starting from 6 months after the PVP, the DO group (n=39) showed a significantly greater reduction in the subtotal storage symptom score than the non-DO group (n=110). When the improvement of storage symptoms was defined as a reduction of >or=50% in the subtotal storage symptom scores, the percentage of patients with improvement in the storage symptoms at 1, 3, 6, and 12 months after the PVP was 13.9%, 25.9%, 47.8%, and 52.9% in the DO group, and 22.2%, 24.4%, 33.3%, and 33.3% in the non-DO group, respectively.
Our results show that storage and voiding symptoms significantly improved after the PVP. In addition, we found that men with DO might show more improvement of storage symptoms, after the PVP, than men without DO.

Download full-text

Full-text

Available from: Hyung Suk Kim, Jun 20, 2014
0 Followers
 · 
151 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: PURPOSE: The authors of this guideline reviewed the literature regarding use of urodynamic testing in common lower urinary tract symptoms. The findings are intended to assist clinicians in the appropriate selection of urodynamic tests, following an evaluation and symptom characterization. MATERIALS AND METHODS: A systematic review of the literature using the MEDLINE® and EMBASE databases (searched from 1/1/90 to 3/10/11) was conducted to identify peer-reviewed publications relevant to using urodynamic tests for diagnosis, determining prognosis, guiding clinical management decisions and improving patient outcomes in patients with various urologic conditions. The review yielded an evidence base of 393 studies after application of inclusion/exclusion criteria. These publications were used to create the evidence basis for characterizing the statements presented in the guideline as Standards, Recommendations or Options. When sufficient evidence existed, the body of evidence for a particular treatment was assigned a strength rating of A (high), B (moderate) or C (low). In the absence of sufficient evidence, additional information is provided as Clinical Principles and Expert Opinion. RESULTS: The evidence-based guideline statements are provided for diagnosis and overall management of common LUTS conditions. CONCLUSIONS: The Panel recognizes that each patient presenting with LUTS is unique. This Guideline is intended to serve as a tool facilitating the most effective utilization of urodynamic testing as part of a comprehensive evaluation of patients presenting with LUTS.
    The Journal of urology 10/2012; 188(6). DOI:10.1016/j.juro.2012.09.081 · 3.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In 2012, the American Urological Association published guidelines on adult urodynamics. On the basis of a review of the available evidence, they established guideline recommendations for urodynamics in adults with stress urinary incontinence/pelvic organ prolapse, overactive bladder/urinary urgency incontinence/mixed urinary incontinence, neurogenic bladder, and lower urinary tract symptoms. This article reviews the practical use of these guidelines in a clinical practice.
    Current Urology Reports 03/2013; 14(3). DOI:10.1007/s11934-013-0317-x · 1.51 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: The Greenlight laser is one of the main alternative treatments for Benign Prostate Hyperplasia (BPH). Ultrasound with contrast (ECUS) is one of the main innovations in radiology that has led to the examination of tissue vascularity. The objective of the study was to measure the impact of Photovaporisation of the Prostate (PVP) on the prostate gland with the ECUS. Methods: We conducted a pilot study to assess the impact of PVP on the prostate by using ECUS intraoperatively (ethical committee approval No. 2012-001451-39). Twelve patients undergoing PVP for symptomatic BPH were enrolled in this study after providing their informed consent. ECUS were performed just before and after PVP in the operating room and at 1 month post operatively. Results: Comparative analysis showed that after PVP, a non-vascularised area with an average thickness of 11.1 mm was observed beyond the operative cavity. The non vascularised area was thinner at 1 month post operatively and disappeared at 6 months for the 6 patients evaluated. This is the first study using contrast-enhanced ultrasound to measure the impact of PVP on the prostate. Our study has the limitations of a pilot study with a small population and a short follow-up. Based on these results we would advise beginners to take into account the necrosis thickness, and to limit the depth of vaporization. Conclusions: Through the use of ECUS, our study demonstrated that a large area of necrosis is induced around the surgical cavity due to the action of the Greenlight laser. Being aware of this phenomenon will certainly reduce the risk of complications induced by surgery.
    Journal of endourology / Endourological Society 07/2013; 27(10). DOI:10.1089/end.2013.0368 · 2.10 Impact Factor
Show more